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Summary 
The cell surface expression of T cell antigen receptors (TCR) is regulated in part by the limiting 
synthesis of the ~" subunit. Utilizing fragments from the 5' region of the human ~" gene, two 
discrete regions that promote transcription were characterized. Both of these elements are located 
within 125 bases of the most 3' site of transcription initiation. The more proximal (3') promoter 
exhibits activity in lymphoid as well as nonlymphoid ceils. In contrast, the more distal (5') promoter 
element functions in a tissue-restricted fashion.  The tissue-specific  promoter is localized to a 
29-base fragment. The sequence of this region is remarkable for a stretch of 11 consecutive purines 
that are required for activity. This element constitutes the only known tissue-specific  promoter 
for an invariant TCR subunit. Consistent with the unique role served by the ~" subunit in assembly 
of the TCtL, this study demonstrates that the expression of the ~" gene is regulated in a fashion 
distinct from other TCR components. 
ecognition of foreign antigens by T  cells is dependent 
on the expression of the multi-subunit TCR. On most 
ceils, the antigen recognition component of this receptor con- 
sists of donaUy derived TCtL-oc/13 heterodimers (for a re- 
view see reference 1). These exist in stable association with 
a  set  of invariant  subunits  that  include the  three related 
members of the CD3 complex and the ~" subunit (for a re- 
view see reference 2). In mature T  calls, ~" is synthesized in 
limiting amounts, and largely regulates the assembly of com- 
plete receptors and their steady state cell surface expression 
(3, 4). Partial receptors, lacking ~', assemble and traverse the 
Golgi apparatus, but are largely targeted for degradation in 
lysosomes (5). The importance of the regulated transcription 
of ~'in T ceU development has been established by the findings 
that ~'-deficient mice exhibit profound defects in T cell devel- 
opment  (6),  whereas mice which  might  overexpress  this 
subunit demonstrate premature inactivation of recombinant 
activating genes (RAG) 1 and 2 accompanied by abnormal 
T cell development (7). ~'is unique among the TCR compo- 
nents in being expressed in human NK cells where it assembles 
with the Fc receptor for IgG (8, 9). It is interesting to note 
that tumor-bearing mice with impaired immune function ex- 
hibit a selective loss of the ~" subunit, with its apparent replace- 
ment by the related Fce-3' subunit (10). A similar loss of ~" 
is seen in tumor-infiltrating T ceils from patients with malig- 
nancies (11, 12). 
The TCIL genes are in general characterized by weak, tissue 
nonspecific, nonclassical promoters, which exhibit little ac- 
tivity in the absence of 5' or 3' enhancers (13-17). The ~" gene 
also lacks classical promoter elements (18, 19) and has mul- 
tiple transcription start sites (18, 19). The analysis of ~" gene 
expression has been limited to the finding of a correlation 
between methylation patterns and ~" mR.NA levels during 
murine thymocyte development (20). We have evaluated the 
5' region of the human ~" gene for elements that are respon- 
sible for its regulated and tissue-specific  expression. 
Materials  and Methods 
Plasmids.  Promoter constructs were generated by cloning frag- 
ments from a human genomic clone, HGZ7 (19), into the promoter- 
less and enhancerless  vector pGL-2 Basic (Promega, Madison, WI), 
upstream of the luciferase gene. Constructs with 3' ends at  -32 
(relative to the most 3' site of transcription initiation) were gener- 
ated by the use of naturally occurring restriction sites and subdoning 
through pGem 3Zf+  (Promega) before insertion into the poly- 
linker of pGb2 Basic from KpnI to HindIII. Constructs with 3' 
ends at + 58 were generated by PCR amplification using genomic 
constructs as templates (19), products were cloned into pGL.2 Basic 
from XhoI to HindIII. A construct that contained a fragment from 
-485 to +58 was generated by ligating the KpnI/PstI fragment 
from a vector containing -485/-32 into a vector already  containing 
-158/+58 after cutting with KpnI and PstI. Fragments from -307 
to -207,  -257 to -168,  -207 to -109,  -169 to -59, and -109 
to -9 were generated by PCR and cloned into pGb2 basic from 
Sad to XhoI. Constructs containing fragments from -159 to -97, 
-  159 to - 126,  - 140 to - 110, and - 125 to - 97 were generated 
by annealing overlapping double-stranded oligonucleotides with 
XhoI compatible ends and cloning into pGb2 basic. 
To generate a 22-bp mutation from -119 to -98 in -307/+ 58 
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TAAGCTAGCTAGCATC  CTTGC~CCTGTCGC~AGGTG), con- 
taining the mutation, and a 3' antisense oligonucleotide (TATATA- 
AGCTTTCCCTCAGAAAGAGC~TGG) were utilized in the PCR 
with -307/+ 58 as a template. Similarly, an antisense oligonucle- 
otide containing the 22-base substitution (GCTAGCTAGC~TAAG- 
ATCGTTCACAGGCAGGAAGCCCTG) and a 5' sense oligonu- 
cleotide  (  TATATCTC  GAG  CCATC  GAGAACTTGTATTTGC  C ) 
were utilized for amplification. The products of these amplificat- 
ions were reamplified with the 5' sense and 3' antisense oligonucle- 
otides (21). The resulting fragment was doned into pGl.r2 Basic. 
Site-directed mutagenesis was performed using the Transformer 
Mutagenesis Kit (Clontech,  Palo Alto,  CA).  CMV-3-Gal  was 
provided by Vinay Jain  and Ian Magrath  (National Institutes  of 
Health). 
Transfections and Activity Assays.  Luciferase  reporter gene con- 
structs were purified by columns (Qiagen Inc., Chatsworth, CA) 
followed by cesium chloride banding; 15/~g of plasmid was used 
in all transfection assays. 500 ng of a B-Gal construct containing 
the CMV promoter was cotransfected in all studies. Transfection 
of T and B cells was carried out by electroporation of 107 cells in 
200/~1 of complete media (3) with 10 mM Hepes in a Gene Pulser 
(Bio-Rad Laboratories, Richmond, CA) at 0.23 kV for Jurkat and 
BJAB, and 0.20 kV for MOLT-4, with a capacitance setting of 960 
/~F. HeLa cells were transfected by calcium phosphate precipitation 
(22). After 18-24 h, cells were pelleted and lysed in 50/~1 of  25 mM 
Tris-phosphate pH 7.8, 2 mM DTT, 10% glycerol, and 1% Triton 
X-100. Postnuclear supernatants were assayed using a Monolight 
2010 luminometer (Analytical  Luminescence  Laboratory,  San Diego, 
CA). The luciferase  activity in 10/~1 of  lysate was determined after 
addition of 100/zl of luciferase assay reagent (20 mM tricine, 2.67 
mM MgSO4, 0.1 mM EUFA, 33.3 mM DTT, 270/zM coenzyme 
A, 470/zM luciferin, and 530/~M ATP, pH 7.8). B-Gal activity 
was determined by incubation of 10/zl of lysate with 167/zl  of 
3-Gal  reagent  1  (10  mM  NaHPO4,  1 mM  MgC12, and  0.01 
mg/ml ofa/~-Gal substrate, AMPGD [Tropix, Bedford, MA]) after 
the injection of 100 pl Emerald Enhance (Tropix). Background lu- 
ciferase  or 3-Gal activities  from mock-transfected  controls were first 
subtracted from the luciferase  or 3-Gal activities of test constructs. 
The luciferase activity from a given sample was then normalized 
to the ~-Gal activity of the same sample, multiplied by 1,000 and 
divided by the normalized luciferase value for pGb2 Basic. 
Results  and  Discussion 
Transcription from the human ~" gene is initiated from mul- 
tiple start sites, the two most prominent of which are at base 
+ 1 and base  -61 (19). Sequences from the 5' region of the 
~" gene were cloned upstream of the luciferase reporter gene 
in the promoterless and enhancerless plasmid pGL2-Basic and 
analyzed in transient transfection assays in the ~'-expressing 
human T  ceU tumor line Jurkat (23). Equivalent luciferase 
activity was found with fragments that extended from - 1471 
to  -32 (-1471/-32) and from  -485 to  -32 (-485/-32) 
(Fig.  1 A). A  third construct,  -685/-32, had comparable 
activity (data not shown). A fragment that extended from 
-  485 to + 58 (- 485/+ 58) was more active than  - 485/- 32, 
indicating that sequences around the 3' transcription start 
site are required for full promoter activity. To further delineate 
the minimum requirements for full activity, other constructs 
with 3' end points at + 58 were evaluated. A  -307/+ 58 frag- 
ment had activity equivalent to  -485/+58.  Additional 5' 
deletions to  -159 and to  -69 resulted in stepwise decreases 
in activity relative to the fully active  -307/+58 construct, 
with  -69/+58 having ,,~25%  of maximal activity. These 
findings suggest that there are multiple elements within the 
5' region of the ~" gene between  -307 and  +58 that con- 
tribute to transcriptional activity. They also establish the ex- 
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Figure 1.  Ddetional  analysis  of the 
~" 5' regulatory region. Luciferase  ac- 
tivity of  the indicated  fragments  of the 
~" gene cloned  in front of the ludfemse 
reporter  gene  are shown normalized  to 
a vector  containing the ludf~rase gene 
alone (pGL2  BASIC). (A)Jurkat  cells, 
(B) Jurkat and HeLa, and (C) nucleo- 
tide sequence  of the region  from - 307 
to +58. (Arrows)  The major  transcrip- 
tion start sites. Three GATA-3 sites at 
- 269, - 263, and - 252 are underlined, 
two minus strand Ets consensus se- 
quences at  -135 and -52 are under- 
lined twice. (,~,.x-,-,)  The  region 
termed  Pz2 (see  text)  is indicated. These 
sequence  data are  available from 
EMBL/GenBank/DDBJ under acces- 
sion number U 14115. -307/-207 
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Figure  2.  Localization  of an upstream promoter in 
Jurkat ceils. (.4) Comparison  of  five  overlapping  fragments 
spanning the region  from -307 to -9 (indicated  sche- 
matically  to the left  of the graph). (B) Evaluation  of mul- 
tiple fragments  contained  within  the -169/-59 fragment. 
Error bars indicate  standard  deviation  of the mean  for tripli- 
cates of a single experiment. 
istence of at least one element in the region from  -69 to 
+ 58 that can function as a core promoter. Because of this, 
the  -69/+58  region shall be referred to as promoter of ~" 
#1  (Pzl) 
The activity of constructs were next compared in Jurkat 
and HeLa (24) cells. Pzl (-69/+58) was active in both cell 
types (Fig. 1 B). Unlike Jurkat, no increase was found in HeLa 
with constructs that extended to  -159 and to  -307. This 
tissue-specific  increase  in activity in the 5' region of the ~" 
gene constitutes the only example of tissue-restricted activity 
in the 5' region ofa gene for an invariant TCIk subunit. The 
nucleotide sequence  of the region implicated in regulating 
transcription from the ~" gene is shown in Fig.  1 C. Of note 
are binding sites for the T  cell-specific  transcription factor 
GATA-3 (17, 25, 26), and for consensus sequences for members 
of the Ets family of transcription factors  (27,  28). 
To ascertain  whether there are elements other than Pzl 
that function as promoters,  five overlapping fragments of 
"~100 bp spanning the region from -307 to -9 were cloned 
into pGL2-Basic (Fig.  2 A).  The  two most  5' fragments 
(- 307/- 207 and  - 257/- 168), which include the GATA-3 
consensus sequences,  had no significant activity in Jurkat, 
whereas the three more 3' fragments (-207/-109,  -169/-59, 
and  -109/-9)  were all active. Only the most 3' fragment 
(-109/-9),  which overlaps  Pzl, was active in HeLa (data 
not shown). The -169/-59 fragment consistently had greater 
activity than the overlapping - 207/- 109 fragment. One in- 
terpretation of this data is that a single tissue-specific promoter 
element in the overlap between - 207/- 109 and - 169/- 59 
is responsible for activity from both fragments, with bases 
unique to  -169/-59 required for full activity. To test this, 
-158/-97  was generated and found to have activity com- 
parable to - 169/-59 (Fig. 2 B). Further characterization  was 
carried out by the generation of three plasmids containing 
smaller overlapping fragments spanning -158 to  -97 (Fig. 
2 B). The most 5' of these (-159/-126)  had little activity 
over pGL2-Basic,  the middle one (- 140/- 110) consistently 
had low but detectable activity, whereas the most 3' frag- 
ment (-125/-97)  demonstrated activity comparable to the 
larger  - 169/- 59 and  - 158/- 97 constructs. The activity 
of -125/-97 decreased by >80% when its orientation was 
reversed (RO- 125/- 97). These findings establish  - 125/- 97 
as a second core promoter element for ~" (Pz2). 
To determine whether Pz2 is a tissue-specific  promoter, 
its activity relative  to Pzl  and to  -169/-59  was assessed 
in HeLa, Jurkat, another ~'-expressing T cell (MOLT-4 [29]), 
and a human B cell lymphoma (BJAB [30]) (Fig. 3). Whereas 
the activity of the downstream promoter (Pzl) was within 
twofold for all cell lines,  Pz2 was 8-10-fold more active in 
Figure 3.  Tissue-specific  expression from the 5' region  of the ~" gene. 
The relative  luciferase  activity  from Pzl (-69/+58),  Pz2 (-125/-97), 
and - 169/- 59 are compared.  This  figure  represents the cumulative  results 
of multiple experiments using these four cell lines. Shown is the mean 
_+ the SE of  the mean. The number  of  points  used  for each  cell  type  ranged 
from 8 to 13. 
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fragment,  -169/-59,  also demonstrated a tissue-restricted 
pattern  of activity. 
To evaluate the transcriptional activity of 5' regions of the 
~" gene, ~" promoter constructs were compared with a phsmid 
in which the expression of the luciferase gene was driven by 
the SV40 early promoter. The  -307/+ 58 fragment and Pz2 
(-125/-97) had activities of 70 and 30%, respectively, rela- 
tive to the SV40 construct,  with  -169/-59  being similar 
in activity to Pz2 (data not shown). This demonstrates that 
the 29-bp Pz2 region has substantial activity. To determine 
its functional relevance  in the context of the fully active 5' 
region, a construct was generated in which the 22 bases from 
-  119 to  - 98 of - 307/+ 58 were mutated (- 307/+ 58.A22; 
Fig. 4 A). Consistent with a role for this region in transcrip- 
tion from the ~" gene,  this  substitution  resulted in a 65% 
decrease in activity when assayed in Jurkat. It is of note how- 
ever, that  -  307/+ 58.A22 was still more active than the Pzl 
element,  suggesting  that  regions  other  than  Pzl  and Pz2 
influence transcription  from the  ~" gene. 
The sequence of the Pz2 region is remarkable for a core 
of 11 consecutive purines (bases  118-108). To assess the re- 
quirements for activity from Pz2, a systematic mutagenesis 
of sets of three consecutive bases within Pz2 was undertaken 
(Fig.  4,  B  and  C).  Changes  in  the  11-base  purine  stretch 
resulted in marked reductions in activity (constructs M2-M4, 
Fig.  4 B).  In contrast,  mutations  at either  the  5' (M1) or 
3' (M6) end of Pz2 had no substantial effect on activity (Fig. 
4 C). Alteration of the nucleotide sequence immediately 3' 
to the purine stretch (MS) reproducibly resulted in a decrease 
in activity of 40-70%. It is apparent from this analysis that 
this purine stretch is important for the promoter activity of 
Pz2. It is interesting to note that the 5' region of the mouse 
~" gene contains a region that is highly homologous to Pz2, 
with 11 consecutive purines, 10 of which are identical to those 
in Pz2 (Hsu, V. and IL. Klausner, personal communication). 
Gel mobility retardation assays for the Pz2 region have been 
carried out using T cell extracts, and specific bands identified 
which comigrated with bands from extracts of HeLa cells 
and B cells (data not shown). This may be indicative of the 
complexity of interactions involved in regulating transcrip- 
tion from this region. 
The requirements for transcription from classical,  TATA- 
containing,  promoters has been extensively analyzed, and it 
is clear that  a complex array of factors are involved in the 
initiation  of transcription  (31,  32).  Less is  known  about 
nonclassical  TATA-less  promoters.  Recent  studies  (33-36) 
suggest  that  transcription  factors  that  bind  to  enhancers 
might also function to facilitate transcription initiation,  and 
may be  involved  in  the  tissue-restricted  activity  of some 
TATA-less promoter elements (37). The trans-acting factors 
responsible for transcription for Pz2 remain to be determined. 
Potential candidates include proteins that bind to purine-rich 
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Analysis of the Pz2 promoter. (.4) Evaluation of a 22-base 
substitution of bases -119 to -98 in the -307/+58 construct. (/3 and 
C) Relative luciferase activity of each of six mutations of the Pz2 pro- 
motet. The position of each of the mutations is indicated above  the Pz2 
sequence  and the actual mutations are indicated below. Error bars indicate 
~- SD from triplicate samples. The data in each panel are from a single 
representative experiment. 
regions  of DNA  such as NFAT (38,  39),  Ikaros  (40,  41), 
and members of the Ets family of transcription  factors (27, 
42, 43). All of these are known to be involved in the regula- 
tion  of lymphoid genes. 
The genes encoding the donally derived TCR subunits 
and the invariant  CD3 complex members are generally charac- 
terized by nontissue-specific core promoters with minimal 
activity, and by enhancers that play a dominant role in deter- 
mining  the  specificity and extent of transcription  (13-17). 
Consistent with the limiting role of ~" in receptor assembly, 
and its unique expression pattern,  ~" is regulated in a distinct 
fashion.  The identification  of Pz2 constitutes the only ex- 
ample  of a  tissue-specific promoter  for an  invariant  TCR 
subunit. Our analysis also demonstrates that, in addition to 
Pzl  and Pz2,  there are other elements in the 5' region of 
the  ~" gene that  have positive effects on transcription.  Fur- 
thermore,  the isolated 5' region of the ~" gene (-307/+58) 
has some activity in nonlymphoid cells, whereas ~" gene ex- 
pression is limited to T cells and NK cells. It is apparent there- 
fore, that inhibitory mechanisms are also employed to main- 
tain  the tissue-restricted  expression of ~'. 
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